» Articles » PMID: 32765256

Intervention of and Its Components on Liver Lipid Metabolism in Spontaneously Hypertensive Rats

Overview
Journal Front Pharmacol
Date 2020 Aug 9
PMID 32765256
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

(Miq.) Miq. ex Havil is widely used in the treatment of hypertension. The extract and its bioactives, rhynchophylline and isorhynchophylline, reduced the blood pressure and fatty content in liver cells. In the present study, the antihypertensive effects of ethanol extract (UET), rhynchophylline (RT) and isorhynchophylline (IT) were investigated in spontaneously hypertensive rats (SHR) using UPLC-Q-Orbitrap/MS based lipidomics approach. Histological changes in the liver were evaluated. Cytolysis and fatty degeneration in the liver tissues were observed in the SHR group. Lipid species in WKY, SHR treated with UET, RT, and IT were plotted to obtain the Orthogonal Projections to Latent Structures Discriminant Analysis (OPLS-DA) score plots. Fifty-six endogenous metabolites in the liver such as glycerides, glycerophospholipids, unsaturated fatty acids, and sphingomyelins were selected as potential hypertension associated biomarkers. In order to further explore the metabolite targets of UET for antihypertensive, student's t test and correlation analysis were performed to recognize the pattern recognition and to select the significant metabolites. Similar and prolonged reduction in blood pressure was observed in all SHR groups treated with UET, RT, and IT, while the metabolite profiles were perturbed slightly compared to that of the untreated SHR. Further analysis showed that only a few common components were observed in both RT and IT, which showed similar antihypertensive effect in spite of the distinct metabolic pathways. These results help in understanding the mechanisms of isomeric ingredients in exhibiting the antihypertensive effect but with different targets.

Citing Articles

The role of Chinese herbal medicine in the regulation of oxidative stress in treating hypertension: from therapeutics to mechanisms.

Jin Z, Lan Y, Li J, Wang P, Xiong X Chin Med. 2024; 19(1):150.

PMID: 39468572 PMC: 11520704. DOI: 10.1186/s13020-024-01022-9.


Elucidating the anti-hypertensive mechanisms of Uncaria rhynchophylla-Alisma plantago-aquatica L: an integrated network pharmacology, cluster analysis, and molecular docking approach.

Yin T, Zhang H, Liu X, Wei D, Ren C, Cui L Front Chem. 2024; 12:1356458.

PMID: 38496269 PMC: 10941343. DOI: 10.3389/fchem.2024.1356458.


Profiles of Metabolic Genes in and Characterization of the Critical Enzyme Involved in the Biosynthesis of Bioactive Compounds-(iso)Rhynchophylline.

Yang M, Yao B, Lin R Biomolecules. 2022; 12(12).

PMID: 36551218 PMC: 9775700. DOI: 10.3390/biom12121790.


LC-MS-based lipidomic analysis of liver tissue sample from spontaneously hypertensive rats treated with extract hawthorn fruits.

Sun L, Chi B, Xia M, Ma Z, Zhang H, Jiang H Front Pharmacol. 2022; 13:963280.

PMID: 36016567 PMC: 9395718. DOI: 10.3389/fphar.2022.963280.


Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction.

Chen Y, Xu Y, Jiang H, Wang L, Zhai J, Zhang T Chin J Integr Med. 2022; 28(10):924-929.

PMID: 35508862 PMC: 9068502. DOI: 10.1007/s11655-022-3676-7.


References
1.
Miao H, Chen H, Pei S, Bai X, Vaziri N, Zhao Y . Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia. Chem Biol Interact. 2015; 228:79-87. DOI: 10.1016/j.cbi.2015.01.023. View

2.
Shi J, Yu J, Chen X, Xu R . Pharmacological actions of Uncaria alkaloids, rhynchophylline and isorhynchophylline. Acta Pharmacol Sin. 2003; 24(2):97-101. View

3.
Zhou J, Zhou S . Isorhynchophylline: A plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases. Fitoterapia. 2012; 83(4):617-26. DOI: 10.1016/j.fitote.2012.02.010. View

4.
Milne S, Ivanova P, Forrester J, Brown H . Lipidomics: an analysis of cellular lipids by ESI-MS. Methods. 2006; 39(2):92-103. DOI: 10.1016/j.ymeth.2006.05.014. View

5.
Nguyen P, Leray V, Diez M, Serisier S, Le Bloch J, Siliart B . Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl). 2008; 92(3):272-83. DOI: 10.1111/j.1439-0396.2007.00752.x. View